胺碘酮治疗急性心肌梗死伴心房颤动的临床效果研究  

Clinical effect of Amiodarone on acute myocardial infarction with atrial fibrillation

作　　者：刘颖 Liu Ying(The Jinzhou District First People's Hospitals of Dalian City,Dalian,Liaoning 116100)

机构地区：[1]大连市金州区第一人民医院,辽宁大连116100

出　　处：《基层医学论坛》2023年第2期16-18,共3页The Medical Forum

摘　　要：目的探讨胺碘酮治疗急性心肌梗死伴心房颤动的临床效果。方法选择2020年1月-2021年6月大连市金州区第一人民医院收治的急性心肌梗死伴心房颤动患者120例,依照用药方案的差异分组,对照组予以利多卡因治疗,研究组予以胺碘酮治疗。对比2组临床治疗效果。结果研究组总有效率比对照组高(P<0.05);药物干预前2组患者QTcd水平无明显差异(P>0.05),经治疗2组患者QTcd水平均下降,且研究组在用药后2 h及48 h的QTcd水平均低于对照组(P<0.05);研究组不良反应发生率低于对照组(P<0.05)。结论对急性心肌梗死伴心房颤动患者施以胺碘酮治疗,可促进疗效提升,改善QTcd水平,且不会增加药物不良反应,值得推广。Objective To explore the clinical effect of Amiodarone in the treatment of acute myocardial infarction with atrial fibrillation.Methods from January 2020 to June 2020,120 patients with acute myocardial infarction(Ami)and atrial fibrillation(AF)were selected and divided into groups according to different medication regimens. The control group was treated with Lidocaine and the study group was treated with Amiodarone.Results The total effective rate of the study group was higher than that of the control group(P<0.05),the QTcd level of the two groups had no significant difference before the intervention(P>0.05),the QTcd level of the two groups decreased after the treatment,the level of QTcd was lower than that of control group(P<0.05);The incidence of adverse reactions in the study group was lower than that in the control group(P<0.05).Conclusion Amiodarone can promote the curative effect and improve QTcd level in patients with acute myocardial infarction and atrial fibrillation. It is worthy to be used.

关 键 词：急性心肌梗死伴心房颤动 胺碘酮 QTcd水平 不良反应 

分 类 号：R541.4[医药卫生—心血管疾病]